• Search
  • Home
  • Teams
  • Departments
  • Platforms & Facilities
  • Partnerships
  • Events
  • Calls
  • Jobs
  • Courses / MOOCs
  • Open Science
  • Why join us?
  • Alumni
  • Login
    • EN
    • FR

Menu

Skip to content
  • Institut Pasteur
  • Research
  • Education
  • Public Health
  • International
  • Careers
Donate
Search anything and hit enter
  • Teams
  • Members
  • Projects
  • Events
  • Calls
  • Jobs
  • publications
  • Software
  • Tools
  • Network
  • Equipment

A little guide for advanced search:

  • Tip 1. You can use quotes "" to search for an exact expression.
    Example: "cell division"
  • Tip 2. You can use + symbol to restrict results containing all words.
    Example: +cell +stem
  • Tip 3. You can use + and - symbols to force inclusion or exclusion of specific words.
    Example: +cell -stem
e.g. searching for members in projects tagged cancer
Search for
Count
IN
OUT
Content 1
  • member
  • team
  • department
  • center
  • program_project
  • nrc
  • whocc
  • project
  • software
  • tool
  • patent
  • Administrative Staff
  • Assistant Professor
  • Associate Professor
  • Clinical Research Assistant
  • Clinical Research Nurse
  • Clinician Researcher
  • Department Manager
  • Dual-education Student
  • Full Professor
  • Honorary Professor
  • Lab assistant
  • Master Student
  • MD-PhD Student
  • Medical Staff
  • Non-permanent Researcher
  • Nursing Staff
  • Permanent Researcher
  • Pharmacist
  • PhD Student
  • Physician
  • Post-doc
  • Prize
  • Project Manager
  • Research Associate
  • Research Engineer
  • Retired scientist
  • Technician
  • Undergraduate Student
  • Veterinary
  • Visiting Scientist
  • Deputy Director of Center
  • Deputy Director of Department
  • Deputy Director of National Reference Center
  • Deputy Head of Facility
  • Director of Center
  • Director of Department
  • Director of Institute
  • Director of National Reference Center
  • Group Leader
  • Head of Facility
  • Head of Operations
  • Head of Structure
  • Honorary President of the Departement
  • Labex Coordinator
  • Laboratory
  • UMR
  • UTechS
  • Junior Group (G5)
  • Technological Pole
  • Platform
  • Collection
  • Group
Content 2
  • member
  • team
  • department
  • center
  • program_project
  • nrc
  • whocc
  • project
  • software
  • tool
  • patent
  • Administrative Staff
  • Assistant Professor
  • Associate Professor
  • Clinical Research Assistant
  • Clinical Research Nurse
  • Clinician Researcher
  • Department Manager
  • Dual-education Student
  • Full Professor
  • Honorary Professor
  • Lab assistant
  • Master Student
  • MD-PhD Student
  • Medical Staff
  • Non-permanent Researcher
  • Nursing Staff
  • Permanent Researcher
  • Pharmacist
  • PhD Student
  • Physician
  • Post-doc
  • Prize
  • Project Manager
  • Research Associate
  • Research Engineer
  • Retired scientist
  • Technician
  • Undergraduate Student
  • Veterinary
  • Visiting Scientist
  • Deputy Director of Center
  • Deputy Director of Department
  • Deputy Director of National Reference Center
  • Deputy Head of Facility
  • Director of Center
  • Director of Department
  • Director of Institute
  • Director of National Reference Center
  • Group Leader
  • Head of Facility
  • Head of Operations
  • Head of Structure
  • Honorary President of the Departement
  • Labex Coordinator
  • Laboratory
  • UMR
  • UTechS
  • Junior Group (G5)
  • Technological Pole
  • Platform
  • Collection
  • Group
Search
  • EN
  • FR
Go back
Scroll to top
Share
Website Terms & Conditions of use
Guides
  • 2025
    Debashis Dhara, Laurence A. Mulard, and Marcel Hollenstein*, Natural, modified and conjugated carbohydratesin nucleic acids, Chem. Soc. Rev. 2025, 54, 2948-2983.
  • 2025
    Dejoux A, Zhu Q, Woolfe A, Godon O, Ellouze S, Mottet G, Castrillon C, Gillis C, Pecalvel C, Ganneau C, Iannascoli B, Lemoine F, Saul F, England P, Reber LL, Gouel-Chéron A, de Chaisemartin L, Haouz A, Millot GA, Bay S, Gérard A, Jönsson F, Chollet-Martin S, Bruhns P, Antibody-secreting cell repertoires hold high-affinity anti-rocuronium specificities that can induce anaphylaxis in vivo., J Allergy Clin Immunol 2025 Jan; (): .
  • 2025
    Grossi V, Cuny P, Militon C, Witwinowski J, Eddhif B, Sylvi L, Nowakowski M, Kosta A, Antheaume I, Cornil J, Dubrac S, Kende J, Gribaldo S, Borrel G, Halophilic archaea produce wax esters and use an alternative fatty acyl-coenzyme A reductase for precursor synthesis., ISME J 2025 Jan; 19(1): .
  • 2024
    Dejoux A, Zhu Q, Ganneau C, Goff OR, Godon O, Lemaitre J, Relouzat F, Huetz F, Sokal A, Vandenberghe A, Pecalvel C, Hunault L, Derenne T, Gillis CM, Iannascoli B, Wang Y, Rose T, Mertens C, Nicaise-Roland P, , England P, Mahévas M, de Chaisemartin L, Le Grand R, Letscher H, Saul F, Pissis C, Haouz A, Reber LL, Chappert P, Jönsson F, Ebo DG, Millot GA, Bay S, Chollet-Martin S, Gouel-Chéron A, Bruhns P, Rocuronium-specific antibodies drive perioperative anaphylaxis but can also function as reversal agents in preclinical models., Sci Transl Med 2024 Sep; 16(764): eado4463.
  • 2023
    Debashis Dhara, Laurence A. Mulard,* Marcel Hollenstein*, Expedient synthesis of l-heptose derived septacidin building blocks from l-glucose, Carbohydr. Res. 2023, 534, 108985.
  • 2022
    van der Put RMF, Smitsman C, de Haan A, Hamzink M, Timmermans H, Uittenbogaard J, Westdijk J, Stork M, Ophorst O, Thouron F, Guerreiro C, Sansonetti PJ, Phalipon A, Mulard LA, , The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella., ACS Cent Sci 2022 Apr; 8(4): 449-460.
  • 2022
    Phalipon A, Mulard LA, , Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine against Shigella: State-of-the-Art for a Monovalent Prototype and Challenges., Vaccines (Basel) 2022 Mar; 10(3): .
  • 2022
    Ropartz D, Fanuel M, Ollivier S, Lissarrague A, Benkoulouche M, Mulard LA, André I, Guieysse D, Rogniaux H, , Combination of High-Resolution Multistage Ion Mobility and Tandem MS with High Energy of Activation to Resolve the Structure of Complex Chemoenzymatically Synthesized Glycans., Anal Chem 2022 02; 94(4): 2279-2287.
  • 2021
    Benkoulouche M, Ben Imeddourene A, Barel LA, Lefebvre D, Fanuel M, Rogniaux H, Ropartz D, Barbe S, Guieysse D, Mulard LA, Remaud-Siméon M, Moulis C, André I, , Computer-aided engineering of a branching sucrase for the glucodiversification of a tetrasaccharide precursor of S. flexneri antigenic oligosaccharides., Sci Rep 2021 10; 11(1): 20294.
  • 2021
    Hosseiniporgham S, Biet F, Ganneau C, Bannantine JP, Bay S, Sechi LA, , A Comparative Study on the Efficiency of Two Mycobacterium avium subsp. paratuberculosis (MAP)-Derived Lipopeptides of L3P and L5P as Capture Antigens in an In-House Milk ELISA Test., Vaccines (Basel) 2021 Sep; 9(9): .
  • 2021
    , Multigram synthesis of an orthogonally-protected pentasaccharide for use as a glycan precursor in a Shigella flexneri 3a conjugate vaccine: application to a ready-for-conjugation decasaccharide, Org. Chem. Front..
  • 2021
    Cohen D, Atsmon J, Artaud C, Meron-Sudai S, Gougeon ML, Bialik A, Goren S, Asato V, Ariel-Cohen O, Reizis A, Dorman A, Hoitink CWG, Westdijk J, Ashkenazi S, Sansonetti P, Mulard LA, Phalipon A, , Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study., Lancet Infect Dis 2021 04; 21(4): 546-558.
  • 2021
    Dhara D, Mulard LA, , Exploratory N-Protecting Group Manipulation for the Total Synthesis of Zwitterionic Shigella sonnei Oligosaccharides., Chemistry 2021 Mar; 27(18): 5694-5711.
  • 2021
    Hu Z, Benkoulouche M, Barel LA, Le Heiget G, Ben Imeddourene A, Le Guen Y, Monties N, Guerreiro C, Remaud-Siméon M, Moulis C, André I, Mulard LA, , Convergent Chemoenzymatic Strategy to Deliver a Diversity of Shigella flexneri Serotype-Specific O-Antigen Segments from a Unique Lightly Protected Tetrasaccharide Core., J Org Chem 2021 02; 86(3): 2058-2075.
  • 2021
    Benkoulouche M, Ben Imeddourene A, Barel LA, Le Heiget G, Pizzut S, Kulyk H, Bellvert F, Bozonnet S, Mulard LA, Remaud-Siméon M, Moulis C, André I, , Redirecting substrate regioselectivity using engineered ΔN123-GBD-CD2 branching sucrases for the production of pentasaccharide repeating units of S. flexneri 3a, 4a and 4b haptens., Sci Rep 2021 01; 11(1): 2474.
  • 2021
    Bay S, Begg D, Ganneau C, Branger M, Cochard T, Bannantine JP, Köhler H, Moyen JL, Whittington RJ, Biet F, , Engineering Synthetic Lipopeptide Antigen for Specific Detection of Mycobacterium avium subsp. paratuberculosis Infection., Front Vet Sci 2021 ; 8(): 637841.
  • 2021
    Köhler H, Liebler-Tenorio E, Hughes V, Stevenson K, Bakker D, Willemsen P, Bay S, Ganneau C, Biet F, Vordermeier HM, , Interferon-γ Response of Mycobacterium avium subsp. paratuberculosis Infected Goats to Recombinant and Synthetic Mycobacterial Antigens., Front Vet Sci 2021 ; 8(): 645251.
  • 2020
    Rosenbaum P, Artaud C, Bay S, Ganneau C, Campone M, Delaloge S, Gourmelon C, Loirat D, Medioni J, Pein F, Sablin MP, Tredan O, Varga A, Leclerc C, , The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients., Cancer Immunol Immunother 2020 May; 69(5): 703-716.
  • 2019
    Vigne J, Bay S, Aid-Launais R, Pariscoat G, Rucher G, Sénémaud J, Truffier A, Anizan N, Even G, Ganneau C, Andreata F, Le Borgne M, Nicoletti A, Le Guludec D, Caligiuri G, Rouzet F, , Cleaved CD31 as a target for in vivo molecular imaging of inflammation., Sci Rep 2019 Dec; 9(1): 19560.
  • 2019
    Friederike Jönsson*, Luc de Chaisemartin*, Vanessa Granger†, Aurélie Gouel-Chéron†, Caitlin M. Gillis, Qianqian Zhu, Fadia Dib, Pascale Nicaise-Roland, Christelle Ganneau, Maria Hurtado-Nedelec, Catherine Paugam-Burtz, Skander Necib, Hawa Keita-Meyer, Matthieu Le Dorze, Bernard Cholley, Olivier Langeron, Laurent Jacob, Benoit Plaud, Marc Fischler, Caroline Sauvan, Marie-Thérèse Guinnepain, Philippe Montravers, Michel Aubier, Sylvie Bay, Catherine Neukirch, Florence Tubach‡, Dan Longrois‡, Sylvie Chollet-Martin‡,§ and Pierre Bruhns‡,§ , An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis, Sci Transl Med. 2019 Jul 10: Vol. 11, Issue 500, eaat1479 DOI: 10.1126/scitranslmed.aat1479 .
  • 2019
    Jönsson F, de Chaisemartin L, Granger V, Gouel-Chéron A, Gillis CM, Zhu Q, Dib F, Nicaise-Roland P, Ganneau C, Hurtado-Nedelec M, Paugam-Burtz C, Necib S, Keita-Meyer H, Le Dorze M, Cholley B, Langeron O, Jacob L, Plaud B, Fischler M, Sauvan C, Guinnepain MT, Montravers P, Aubier M, Bay S, Neukirch C, Tubach F, Longrois D, Chollet-Martin S, Bruhns P, , An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis., Sci Transl Med 2019 Jul; 11(500): .
  • 2019
    Barel LA, Mulard LA, , Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human., Hum Vaccin Immunother 2019 ; 15(6): 1338-1356.
  • 2018
    García-Weber D, Dangeard AS, Cornil J, Thai L, Rytter H, Zamyatina A, Mulard LA, Arrieumerlou C, , ADP-heptose is a newly identified pathogen-associated molecular pattern of Shigella flexneri., EMBO Rep 2018 12; 19(12): .
  • 2018
    Kunstmann S, Scheidt T, Buchwald S, Helm A, Mulard LA, Fruth A, Barbirz S, , Bacteriophage Sf6 Tailspike Protein for Detection of Shigella flexneri Pathogens., Viruses 2018 08; 10(8): .
  • 2017
    Li T, Vandesquille M, Bay S, Dhenain M, Delatour B, Lafaye P, , Selection of similar single domain antibodies from two immune VHH libraries obtained from two alpacas by using different selection methods., Immunol Lett 2017 Aug; 188(): 89-95.
  • 2017
    Bannantine JP, Etienne G, Laval F, Stabel JR, Lemassu A, Daffé M, Bayles DO, Ganneau C, Bonhomme F, Branger M, Cochard T, Bay S, Biet F, , Cell wall peptidolipids of Mycobacterium avium: from genetic prediction to exact structure of a nonribosomal peptide., Mol Microbiol 2017 Aug; 105(4): 525-539.
  • 2017
    Pancrace C, Jokela J, Sassoon N, Ganneau C, Desnos-Ollivier M, Wahlsten M, Humisto A, Calteau A, Bay S, Fewer DP, Sivonen K, Gugger M, Rearranged Biosynthetic Gene Cluster and Synthesis of Hassallidin E in Planktothrix serta PCC 8927, ACS Chem Biol 2017 Jul; 12(7): 1796-1804.
  • 2017
    Briard B, Rasoldier V, Bomme P, ElAouad N, Guerreiro C, Chassagne P, Muszkieta L, Latgé JP, Mulard L, Beauvais A, , Dirhamnolipids secreted from Pseudomonas aeruginosa modify anjpegungal susceptibility of Aspergillus fumigatus by inhibiting β1,3 glucan synthase activity., ISME J 2017 07; 11(7): 1578-1591.
  • 2017
    Christelle Ganneau, Catherine Simenel, Emeline Emptas, Tiphanie Courtiol, Yves-Marie Coïc, Cécile Artaud, Edith Dériaud, Frédéric Bonhomme, Muriel Delepierre, Claude Leclerc, Richard Lo-Man and Sylvie Bay, Large-scale synthesis and structural analysis of a synthetic glycopeptide dendrimer as an anti-cancer vaccine candidate, Organic & Biomolecular Chemistry, 2017, 15, 114 - 123.
  • 2017
    Vandesquille M, Li T, Po C, Ganneau C, Lenormand P, Dudeffant C, Czech C, Grueninger F, Duyckaerts C, Delatour B, Dhenain M, Lafaye P, Bay S, , Chemically-defined camelid antibody bioconjugate for the magnetic resonance imaging of Alzheimer’s disease., MAbs 2017 ; 9(6): 1016-1027.
  • 2016
    Li T, Vandesquille M, Koukouli F, Dudeffant C, Youssef I, Lenormand P, Ganneau C, Maskos U, Czech C, Grueninger F, Duyckaerts C, Dhenain M, Bay S, Delatour B, Lafaye P, , Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets., J Control Release 2016 Dec; 243(): 1-10.
  • 2016
    Connell BJ, Sadir R, Baleux F, Laguri C, Kleman JP, Luo L, Arenzana-Seisdedos F, Lortat-Jacob H, Heparan sulfate differentially controls CXCL12α- and CXCL12γ-mediated cell migration through differential presentation to their receptor CXCR4, Sci Signal 2016 Nov;9(452):ra107.
  • 2016
    Ariën KK, Baleux F, Desjardins D, Porrot F, Coïc YM, Michiels J, Bouchemal K, Bonnaffé D, Bruel T, Schwartz O, Le Grand R, Vanham G, Dereuddre-Bosquet N, Lortat-Jacob H, CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge, Sci Rep 2016 Oct;6:34829.
  • 2016
    Boutet J, Blasco P, Guerreiro C, Thouron F, Dartevelle S, Nato F, Cañada FJ, Ardá A, Phalipon A, Jiménez-Barbero J, Mulard LA, Detailed Investigation of the Immunodominant Role of O-Antigen Stoichiometric O-Acetylation as Revealed by Chemical Synthesis, Immunochemistry, Solution Conformation and STD-NMR Spectroscopy for Shigella flexneri 3a, Chemistry 2016 Jul;22(31):10892-911.
  • 2016
    Hu Z, Bongat White AF, Mulard LA, , Efficient Iterative Synthesis of O-Acetylated Tri- to Pentadecasaccharides Related to the Lipopolysaccharide of Shigella flexneri Type 3 a through Di- and Trisaccharide Glycosyl Donors., Chem Asian J 2017 Feb; 12(4): 419-439.
  • 2016
    van der Put RM, Kim TH, Guerreiro C, Thouron F, Hoogerhout P, Sansonetti PJ, Westdijk J, Stork M, Phalipon A, Mulard LA, A Synthetic Carbohydrate Conjugate Vaccine Candidate against Shigellosis: Improved Bioconjugation and Impact of Alum on Immunogenicity, Bioconjug. Chem. 2016 Mar;.
  • 2016
    Laubreton D, Bay S, Sedlik C, Artaud C, Ganneau C, Dériaud E, Viel S, Puaux AL, Amigorena S, Gérard C, Lo-Man R, Leclerc C, , The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity., Cancer Immunol Immunother 2016 Mar; 65(3): 315-25.
  • 2016
    Niegowska M, Rapini N, Biet F, Piccinini S, Bay S, Lidano R, Manca Bitti ML, Sechi LA, , Seroreactivity against Specific L5P Antigen from Mycobacterium avium subsp. paratuberculosis in Children at Risk for T1D., PLoS One 2016 ; 11(6): e0157962.
  • 2015
    Holbert S, Branger M, Souriau A, Lamoureux B, Ganneau C, Richard G, Cochard T, Tholoniat C, Bay S, Winter N, Moyen JL, Biet F, , Interferon gamma response to Mycobacterium avium subsp. paratuberculosis specific lipopentapeptide antigen L5P in cattle., Res Vet Sci 2015 Oct; 102(): 118-21.
  • 2015
    Salamone S, Guerreiro C, Cambon E, Hargreaves JM, Tarrat N, Remaud-Siméon M, André I, Mulard LA, Investigation on the synthesis of Shigella flexneri-specific oligosaccharides using disaccharides as potential transglucosylase acceptor substrates, J. Org. Chem. 2015 Sep;.
  • 2015
    Salamone S, Guerreiro C, Cambon E, André I, Remaud-Siméon M, Mulard LA, Programmed chemo-enzymatic synthesis of the oligosaccharide component of a carbohydrate-based antibacterial vaccine candidate, Chem. Commun. (Camb.) 2015 Feb;51(13):2581-4.
  • 2015
    Profantová B, Coïc YM, Profant V, Štěpánek J, Kopecký V, Turpin PY, Alpert B, Zentz C, Organization of the MADS box from human SRF revealed by tyrosine perturbation, J Phys Chem B 2015 Feb;119(5):1793-801.
  • 2014
    Agnememel A, Traincard F, Dartevelle S, Mulard L, Mahamane AE, Oukem-Boyer OO, Denizon M, Kacou-N Douba A, Dosso M, Gake B, Lombart JP, Taha MK, , Development and evaluation of a dipstick diagnostic test for Neisseria meningitidis serogroup X., J Clin Microbiol 2015 Feb; 53(2): 449-54.
  • 2014
    Hernández B, Coïc YM, Baron B, Kruglik SG, Pflüger F, Cohen R, Carelli C, Ghomi M, Low concentration structural dynamics of lanreotide and somatostatin-14, Biopolymers 2014 Oct;101(10):1019-28.
  • 2014
    Pfister HB, Mulard LA, Synthesis of the zwitterionic repeating unit of the O-antigen from Shigella sonnei and chain elongation at both ends, Org. Lett. 2014 Sep;16(18):4892-5.
  • 2014
    Hargreaves JM, Le Guen Y, Guerreiro C, Descroix K, Mulard LA, Linear synthesis of the branched pentasaccharide repeats of O-antigens from Shigella flexneri 1a and 1b demonstrating the major steric hindrance associated with type-specific glucosylation, Org. Biomol. Chem. 2014 Oct;12(39):7728-49.
  • 2014
    Migliorini E, Thakar D, Sadir R, Pleiner T, Baleux F, Lortat-Jacob H, Coche-Guerente L, Richter RP, Well-defined biomimetic surfaces to characterize glycosaminoglycan-mediated interactions on the molecular, supramolecular and cellular levels, Biomaterials 2014 Oct;35(32):8903-15.
  • 2014
    Gauthier C, Chassagne P, Theillet FX, Guerreiro C, Thouron F, Nato F, Delepierre M, Sansonetti PJ, Phalipon A, Mulard LA, Non-stoichiometric O-acetylation of Shigella flexneri 2a O-specific polysaccharide: synthesis and antigenicity, Org. Biomol. Chem. 2014 Jun;12(24):4218-32.
  • 2013
    Urbach C, Halila S, Guerreiro C, Driguez H, Mulard LA, Armand S, CGTase-catalysed cis-glucosylation of L-rhamnosides for the preparation of Shigella flexneri 2a and 3a haptens, Chembiochem 2014 Jan;15(2):293-300.
  • 2013
    Chassagne P, Raibaut L, Guerreiro C, Mulard LA, Concise synthesis of di- and trisaccharides related to the O-antigens from Shigella flexneri serotypes 6 and 6a, based on late stage mono-O-acetylation and/or site-selective oxydation, Tetrahedron 2013; 69:10337-50.
  • 2013
    Noya V, Bay S, Festari MF, García EP, Rodriguez E, Chiale C, Ganneau C, Baleux F, Astrada S, Bollati-Fogolín M, Osinaga E, Freire T, Mucin-like peptides from Echinococcus granulosus induce antitumor activity, Int. J. Oncol. 2013 Sep;43(3):775-84.
  • 2013
    van Vliet SJ, Bay S, Vuist IM, Kalay H, García-Vallejo JJ, Leclerc C, van Kooyk Y, MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion, J. Leukoc. Biol. 2013 Aug;94(2):315-23.
  • 2013
    Chassagne P, Fontana C, Guerreiro C, Gauthier C, Phalipon, A, Widmalm G, Mulard LA, Structural studies of the O-acetyl containing O-antigen from a Shigella flexneri serotype 6 strain and synthesis of oligosaccharide fragments thereof, Eur. J. Org. Chem. 2013, 4085–106.
  • 2013
    Mazal D, Lo-Man R, Bay S, Pritsch O, Dériaud E, Ganneau C, Medeiros A, Ubillos L, Obal G, Berois N, Bollati-Fogolin M, Leclerc C, Osinaga E, Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer, Cancer Immunol. Immunother. 2013 Jun;62(6):1107-22.
  • 2013
    Galvagnion C, Montaville P, Coïc YM, Jamin N, Production and initial structural characterization of the TM4TM5 helix-loop-helix domain of the translocator protein, J. Pept. Sci. 2013 Feb;19(2):102-9.
  • 2012
    Champion E, Guérin F, Moulis C, Barbe S, Tran TH, Morel S, Descroix K, Monsan P, Mourey L, Mulard LA, Tranier S, Remaud-Siméon M, André I, Applying pairwise combinations of amino acid mutations for sorting out highly efficient glucosylation tools for chemo-enzymatic synthesis of bacterial oligosaccharides, J. Am. Chem. Soc. 2012 Nov;134(45):18677-88.
  • 2012
    Rueda P, Richart A, Récalde A, Gasse P, Vilar J, Guérin C, Lortat-Jacob H, Vieira P, Baleux F, Chretien F, Arenzana-Seisdedos F, Silvestre JS, Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions, Circulation 2012 Oct;126(15):1882-95.
  • 2012
    Hernández B, Coïc YM, Kruglik SG, Carelli C, Cohen R, Ghomi M, Octreotide used for probing the type-II’ β-turn CD and Raman markers, J Phys Chem B 2012 Aug;116(31):9337-45.
  • 2012
    Coïc YM, Baleux F, Poyraz Ö, Thibeaux R, Labruyere E, Chretien F, Sobhani I, Lazure T, Wyplosz B, Schneider G, Mulard L, Sansonetti PJ, Marteyn BS, Design of a specific colonic mucus marker using a human commensal bacterium cell surface domain, J. Biol. Chem. 2012 May;287(19):15916-22.
  • 2012
    Connell BJ, Baleux F, Coic YM, Clayette P, Bonnaffé D, Lortat-Jacob H, A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage, Chem. Biol. 2012 Jan;19(1):131-9.
  • 2012
    Theillet FX, Chassagne P, Delepierre M, Phalipon A, Mulard LA , Multidisciplinary approaches to study O-antigen:antibody recognition in support of the development of synthetic carbohydrate-based enteric vaccines, “Anticarbohydrate Antibodies - from molecular basis to clinical applications”, P. Kosma and S. Müller-Loennies Eds, Springer-Verlag GmbH, New York, Vienna 2012, pp 1-36.
  • 2011
    Chiaravalli J, Fontan E, Fsihi H, Coic YM, Baleux F, Véron M, Agou F, Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO, Biochem. Pharmacol. 2011 Nov;82(9):1163-74.
  • 2011
    Theillet FX, Frank M, Vulliez-Le Normand B, Simenel C, Hoos S, Chaffotte A, Bélot F, Guerreiro C, Nato F, Phalipon A, Mulard LA, Delepierre M, Dynamic aspects of antibody:oligosaccharide complexes characterized by molecular dynamics simulations and saturation transfer difference nuclear magnetic resonance, Glycobiology 2011 Dec;21(12):1570-9.
  • 2011
    Delaune A, Poupel O, Mallet A, Coic YM, Msadek T, Dubrac S, Peptidoglycan crosslinking relaxation plays an important role in Staphylococcus aureus WalKR-dependent cell viability, PLoS ONE 2011;6(2):e17054.
  • 2010
    Freire T, Lo-Man R, Bay S, Leclerc C, Tn glycosylation of the MUC6 protein modulates its immunogenicity and promotes the induction of Th17-biased T cell responses, J. Biol. Chem. 2011 Mar;286(10):7797-811.
  • 2010
    Theillet FX, Simenel C, Guerreiro C, Phalipon A, Mulard LA, Delepierre M, Effects of backbone substitutions on the conformational behavior of Shigella flexneri O-antigens: implications for vaccine strategy, Glycobiology 2011 Jan;21(1):109-21.
  • 2010
    Freire T, Zhang X, Dériaud E, Ganneau C, Vichier-Guerre S, Azria E, Launay O, Lo-Man R, Bay S, Leclerc C, Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant, Blood 2010 Nov;116(18):3526-36.
  • 2010
    Champion E, Moulis C, Morel S, Mulard LA, Monsan P, Remaud-Siméon M, André I, A pH-based high-throughput screening of sucrose-utilizing transglucosidases for the development of novel enzymatic glucosylation tools, ChemCatChem 2010; 2: 969-75.
  • 2010
    Coïc YM, Lan CL, Neumann JM, Jamin N, Baleux F, Slightly modifying pseudoproline dipeptides incorporation strategy enables solid phase synthesis of a 54 AA fragment of caveolin-1 encompassing the intramembrane domain, J. Pept. Sci. 2010 Feb;16(2):98-104.
  • 2009
    Hernández B, Carelli C, Coïc YM, De Coninck J, Ghomi M, Vibrational analysis of amino acids and short peptides in aqueous media. V. The effect of the disulfide bridge on the structural features of the peptide hormone somatostatin-14, J Phys Chem B 2009 Sep;113(38):12796-803.
  • 2009
    Baleux F, Loureiro-Morais L, Hersant Y, Clayette P, Arenzana-Seisdedos F, Bonnaffé D, Lortat-Jacob H, A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry, Nat. Chem. Biol. 2009 Oct;5(10):743-8.
  • 2009
    Mulard LA, Phalipon A, From epitope characterization to the design of semi-synthetic glycoconjugate vaccines against Shigella flexneri 2a infection, ACS Symp Ser No. 989, R. Roy Ed, American Chemical Society, Washington, DC, USA 2009, pp 105-136.
  • 2009
    Said Hassane F, Phalipon A, Tanguy M, Guerreiro C, Bélot F, Frisch B, Mulard LA, Schuber F, Rational design and immunogenicity of liposome-based diepitope constructs: application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen, Vaccine 2009 Aug;27(39):5419-26.
  • 2009
    Champion E, André I, Moulis C, Boutet J, Descroix K, Morel S, Monsan P, Mulard LA, Remaud-Siméon M, Design of alpha-transglucosidases of controlled specificity for programmed chemoenzymatic synthesis of antigenic oligosaccharides, J. Am. Chem. Soc. 2009 Jun;131(21):7379-89.
  • 2009
    Boutet J, Guerreiro C, Mulard LA, Efficient synthesis of six tri- to hexasaccharide fragments of Shigella flexneri serotypes 3a and/or X O-antigen, including a study on acceptors containing N-trichloroacetylglucosamine versus N-acetylglucosamine, J. Org. Chem. 2009 Apr;74(7):2651-70.
  • 2009
    Bay S, Fort S, Birikaki L, Ganneau C, Samain E, Coïc YM, Bonhomme F, Dériaud E, Leclerc C, Lo-Man R, Induction of a melanoma-specific antibody response by a monovalent, but not a divalent, synthetic GM2 neoglycopeptide, ChemMedChem 2009 Apr;4(4):582-7.
  • 2009
    Theillet FX, Saul FA, Vulliez-Le Normand B, Hoos S, Felici F, Weintraub A, Mulard LA, Phalipon A, Delepierre M, Bentley GA, Structural mimicry of O-antigen by a peptide revealed in a complex with an antibody raised against Shigella flexneri serotype 2a, J. Mol. Biol. 2009 May;388(4):839-50.
  • 2009
    Champion C, André I, Mulard LA, Monsan P, Remaud-Siméon M, Morel S, Synthesis of L-rhamnose and N-acetyl-D-glucosamine derivatives with glucansucrases, J. Carbohydr. Chem. 2009; 28: 142-60.
  • 2009
    Phalipon A, Tanguy M, Grandjean C, Guerreiro C, Bélot F, Cohen D, Sansonetti PJ, Mulard LA, A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection, J. Immunol. 2009 Feb;182(4):2241-7.
  • 2008
    Boutet J, Mulard LA, Synthesis of 2 tetra- and 4 pentasaccharide fragments of Shigella flexneri serotypes 3a and/or X O-antigens from a common tetrasaccharide intermediate, Eur. J. Org. Chem. 2008: 5526–5542.
  • 2008
    Boutet J, Guerreiro C, Mulard LA, Synthesis of branched tri- to pentasaccharides representative of fragments of Shigella flexneri serotypes 3a and/or X O-antigens, Tetrahedron 2008; 64: 10558-72.
  • 2008
    Grandjean C, Boutonnier A, Dassy B, Fournier JM, Mulard LA, Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba, Glycoconj. J. 2009 Jan;26(1):41-55.
  • 2008
    Phalipon A, Mulard LA, Sansonetti PJ, Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path?, Microbes Infect. 2008 Jul;10(9):1057-62.
  • 2008
    Vulliez-Le Normand B, Saul FA, Phalipon A, Bélot F, Guerreiro C, Mulard LA, Bentley GA, Structures of synthetic O-antigen fragments from serotype 2a Shigella flexneri in complex with a protective monoclonal antibody, Proc. Natl. Acad. Sci. U.S.A. 2008 Jul;105(29):9976-81.
  • 2008
    Boutet, J.; Kim, T. H.; Guerreiro, C.; Mulard, L. A., Efficient route to orthogonally protected precursors of 2-acylamino-2-deoxy-3-O-substituted--D-glucopyranose derivatives and use thereof, Tetrahedron Lett. 2008; 49: 5339-42.
  • 2008
    Lagane B, Chow KY, Balabanian K, Levoye A, Harriague J, Planchenault T, Baleux F, Gunera-Saad N, Arenzana-Seisdedos F, Bachelerie F, CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome, Blood 2008 Jul;112(1):34-44.
  • 2008
    Topalis D, Alvarez K, Barral K, Munier-Lehmann H, Schneider B, Véron M, Guerreiro C, Mulard L, El-Amri C, Canard B, Deville-Bonne D, Acyclic phosphonate nucleotides and human adenylate kinases: impact of a borano group on alpha-P position, Nucleosides Nucleotides Nucleic Acids 2008 Apr;27(4):319-31.
  • 2008
    Murail S, Robert JC, Coïc YM, Neumann JM, Ostuni MA, Yao ZX, Papadopoulos V, Jamin N, Lacapère JJ, Secondary and tertiary structures of the transmembrane domains of the translocator protein TSPO determined by NMR. Stabilization of the TSPO tertiary fold upon ligand binding, Biochim. Biophys. Acta 2008 Jun;1778(6):1375-81.
  • 2008
    Chalabaev S, Turlin E, Bay S, Ganneau C, Brito-Fravallo E, Charles JF, Danchin A, Biville F, Cinnamic acid, an autoinducer of its own biosynthesis, is processed via Hca enzymes in Photorhabdus luminescens, Appl. Environ. Microbiol. 2008 Mar;74(6):1717-25.
  • 2008
    Guiffo-Soh G, Hernandez B, Coïc YM, Boukhalfa-Heniche FZ, Fadda G, Ghomi M, Vibrational analysis of amino acids and short peptides in hydrated media. 3. Successive KL repeats induce highly stable beta-strands capable of forming non-H-bonded aggregates, J Phys Chem B 2008 Jan;112(4):1282-9.
  • 2007
    Ruiz-Argüello MB, Smith VP, Campanella GS, Baleux F, Arenzana-Seisdedos F, Luster AD, Alcami A, An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain, J. Virol. 2008 Jan;82(2):917-26.
  • 2007
    Guiffo-Soh G, Hernandez B, Coïc YM, Boukhalfa-Heniche FZ, Ghomi M, Vibrational analysis of amino acids and short peptides in hydrated media. II. Role of KLLL repeats to induce helical conformations in minimalist LK-peptides, J Phys Chem B 2007 Nov;111(43):12563-72.
  • 2007
    Wyler E, Kaminska M, Coïc YM, Baleux F, Véron M, Agou F, Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO, Protein Sci. 2007 Sep;16(9):2013-22.
  • 2007
    Chamot-Rooke J, van der Rest G, Dalleu A, Bay S, Lemoine J, The combination of electron capture dissociation and fixed charge derivatization increases sequence coverage for O-glycosylated and O-phosphorylated peptides, J. Am. Soc. Mass Spectrom. 2007 Aug;18(8):1405-13.
  • 2007
    Mulard L, [Carbohydrates and vaccines: from purified polysaccharides to semi-synthetic glycoconjugate vaccines], Ann Pharm Fr 2007 Jan;65(1):14-32.
  • 2006
    Freire T, Bay S, Vichier-Guerre S, Lo-Man R, Leclerc C, Carbohydrate antigens: synthesis aspects and immunological applications in cancer, Mini Rev Med Chem 2006 Dec;6(12):1357-73.
  • 2006
    Freire T, D'Alayer J, Bay S, Efficient monitoring of enzymatic conjugation reaction by surface-enhanced laser desorption/ionization time of flight mass spectrometry for process optimization, Bioconjug. Chem. 2006 Mar-Apr;17(2):559-64.
  • 2006
    Phalipon A, Costachel C, Grandjean C, Thuizat A, Guerreiro C, Tanguy M, Nato F, Vulliez-Le Normand B, Bélot F, Wright K, Marcel-Peyre V, Sansonetti PJ, Mulard LA, Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glycoconjugate vaccine, J. Immunol. 2006 Feb;176(3):1686-94.
  • 2006
    Freire T, Lo-Man R, Piller F, Piller V, Leclerc C, Bay S, Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination, Glycobiology 2006 May;16(5):390-401.
  • 2006
    Hernández B, Boukhalfa-Heniche FZ, Seksek O, Coïc YM, Ghomi M, Secondary conformation of short lysine- and leucine-rich peptides assessed by optical spectroscopies: effect of chain length, concentration, solvent, and time, Biopolymers 2006 Jan;81(1):8-19.
  • 2005
    Clément MJ, Fortuné A, Phalipon A, Marcel-Peyre V, Simenel C, Imberty A, Delepierre M, Mulard LA, Toward a better understanding of the basis of the molecular mimicry of polysaccharide antigens by peptides: the example of Shigella flexneri 5a, J. Biol. Chem. 2006 Jan;281(4):2317-32.
  • 2005
    Grandjean C, Boutonnier A, Guerreiro C, Fournier JM, Mulard LA, On the preparation of carbohydrate-protein conjugates using the traceless Staudinger ligation, J. Org. Chem. 2005 Sep;70(18):7123-32.
  • 2005
    Coïc YM, Vincent M, Gallay J, Baleux F, Mousson F, Beswick V, Neumann JM, de Foresta B, Single-spanning membrane protein insertion in membrane mimetic systems: role and localization of aromatic residues, Eur. Biophys. J. 2005 Dec;35(1):27-39.
  • 2005
    Matamoros T, Deval J, Guerreiro C, Mulard L, Canard B, Menéndez-Arias L, Suppression of multidrug-resistant HIV-1 reverse transcriptase primer unblocking activity by alpha-phosphate-modified thymidine analogues, J. Mol. Biol. 2005 Jun;349(3):451-63.
  • 2005
    Lorin C, Saidi H, Belaid A, Zairi A, Baleux F, Hocini H, Bélec L, Hani K, Tangy F, The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro, Virology 2005 Apr;334(2):264-75.
  • 2005
    Croixmarie V, Briki F, David G, Coïc YM, Ovtracht L, Doucet J, Jamin N, Sanson A, A cylinder-shaped double ribbon structure formed by an amyloid hairpin peptide derived from the beta-sheet of murine PrP: an X-ray and molecular dynamics simulation study, J. Struct. Biol. 2005 Jun;150(3):284-99.
  • 2005
    Bélot F, Guerreiro C, Baleux F, Mulard LA, Synthesis of two linear PADRE conjugates bearing a deca- or pentadecasaccharide B epitope as potential synthetic vaccines against Shigella flexneri serotype 2a infection, Chemistry 2005 Feb;11(5):1625-35.
  • 2005
    Alvarez K, Deval J, Selmi B, Barral K, Boretto J, Guerreiro C, Mulard L, Sarfati R, Canard B, Borano-nucleotides: new analogues to circumvent HIV-1 RT-mediated nucleoside drug-resistance, Nucleosides Nucleotides Nucleic Acids 2005;24(5-7):419-21.
  • 2004
    Deval J, Alvarez K, Selmi B, Bermond M, Boretto J, Guerreiro C, Mulard L, Canard B, Mechanistic insights into the suppression of drug resistance by human immunodeficiency virus type 1 reverse transcriptase using alpha-boranophosphate nucleoside analogs, J. Biol. Chem. 2005 Feb;280(5):3838-46.
  • 2004
    Balabanian K, Lagane B, Pablos JL, Laurent L, Planchenault T, Verola O, Lebbe C, Kerob D, Dupuy A, Hermine O, Nicolas JF, Latger-Cannard V, Bensoussan D, Bordigoni P, Baleux F, Le Deist F, Virelizier JL, Arenzana-Seisdedos F, Bachelerie F, WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12, Blood 2005 Mar;105(6):2449-57.
  • 2004
    Agou F, Courtois G, Chiaravalli J, Baleux F, Coïc YM, Traincard F, Israël A, Véron M, Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (nemo) oligomerization, J. Biol. Chem. 2004 Dec;279(52):54248-57.
  • 2004
    Bay S, Huteau V, Zarantonelli ML, Pires R, Ughetto-Monfrin J, Taha MK, England P, Lafaye P, , Phosphorylcholine-carbohydrate-protein conjugates efficiently induce hapten-specific antibodies which recognize both Streptococcus pneumoniae and Neisseria meningitidis: a potential multitarget vaccine against respiratory infections., J Med Chem 2004 Jul; 47(16): 3916-9.
  • 2004
    Lo-Man R, Vichier-Guerre S, Perraut R, Dériaud E, Huteau V, BenMohamed L, Diop OM, Livingston PO, Bay S, Leclerc C, A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates, Cancer Res. 2004 Jul;64(14):4987-94.
  • 2004
    Vichier-Guerre S, Lo-Man R, Huteau V, Dériaud E, Leclerc C, Bay S, Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen, Bioorg. Med. Chem. Lett. 2004 Jul;14(13):3567-70.
  • 2004
    Mulard LA, Guerreiro C, Total synthesis of a tetra- and two pentasaccharide fragments of the O-specific polysaccharide of Shigella flexneri serotype 2a, Tetrahedron 2004; 60: 2475-88.
  • 2004
    Benarroch D, Egloff MP, Mulard L, Guerreiro C, Romette JL, Canard B, A structural basis for the inhibition of the NS5 dengue virus mRNA 2′-O-methyltransferase domain by ribavirin 5′-triphosphate, J. Biol. Chem. 2004 Aug;279(34):35638-43.
  • 2004
    Wright K, Guerreiro C, Laurent I, Baleux F, Mulard LA, Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease, Org. Biomol. Chem. 2004 May;2(10):1518-27.
  • 2004
    Boukhalfa-Heniche FZ, Hernández B, Gaillard S, Coïc YM, Huynh-Dinh T, Lecouvey M, Seksek O, Ghomi M, Complex formation and vectorization of a phosphorothioate oligonucleotide with an amphipathic leucine- and lysine-rich peptide: study at molecular and cellular levels, Biopolymers 2004 Apr;73(6):727-34.
  • 2004
    Bélot F, Wright K, Costachel C, Phalipon A, Mulard LA, Blockwise approach to fragments of the O-specific polysaccharide of Shigella flexneri serotype 2a: convergent Synthesis of a decasaccharide representative of a dimer of the branched repeating unit, J. Org. Chem. 2004 Feb;69(4):1060-74.
  • 2003
    Clément MJ, Imberty A, Phalipon A, Pérez S, Simenel C, Mulard LA, Delepierre M, Conformational studies of the O-specific polysaccharide of Shigella flexneri 5a and of four related synthetic pentasaccharide fragments using NMR and molecular modeling, J. Biol. Chem. 2003 Nov;278(48):47928-36.
  • 2003
    Gallois-Montbrun S, Chen Y, Dutartre H, Sophys M, Morera S, Guerreiro C, Schneider B, Mulard L, Janin J, Veron M, Deville-Bonne D, Canard B, Structural analysis of the activation of ribavirin analogs by NDP kinase: comparison with other ribavirin targets, Mol. Pharmacol. 2003 Mar;63(3):538-46.
  • 2002
    Chanel C, Staropoli I, Baleux F, Amara A, Valenzuela-Fernandez A, Virelizier JL, Arenzana-Seisdedos F, Altmeyer R, Low levels of co-receptor CCR5 are sufficient to permit HIV envelope-mediated fusion with resting CD4 T cells, AIDS 2002 Nov;16(17):2337-40.
  • 2002
    Mousson F, Coïc YM, Baleux F, Beswick V, Sanson A, Neumann JM, Deciphering the role of individual acyl chains in the interaction network between phosphatidylserines and a single-spanning membrane protein, Biochemistry 2002 Nov;41(46):13611-6.
  • 2002
    Bélot F, Costachel C, Wright K, Phalipon A, Mulard LA, Synthesis of the methyl glycoside of a branched octasaccharide fragment specific for the Shigella flexneri serotype 2a O-antigen, Tetrahedron Lett. 2002; 43: 8215-8.
  • 2002
    Jamin N, Coïc YM, Landon C, Ovtracht L, Baleux F, Neumann JM, Sanson A, Most of the structural elements of the globular domain of murine prion protein form fibrils with predominant beta-sheet structure, FEBS Lett. 2002 Oct;529(2-3):256-60.
  • 2002
    Gallois-Montbrun S, Schneider B, Chen Y, Giacomoni-Fernandes V, Mulard L, Morera S, Janin J, Deville-Bonne D, Veron M, Improving nucleoside diphosphate kinase for antiviral nucleotide analogs activation, J. Biol. Chem. 2002 Oct;277(42):39953-9.
  • 2002
    Mulard LA, Clément MJ, Imberty A, Delepierre M, Convergent synthesis, NMR and conformational analysis of tetra- and pentasaccharide haptens of the Shigella flexneri 5a O-specific polysaccharide, Eur. J. Org. Chem. 2002, 2486-98.
  • 2002
    Valenzuela-Fernández A, Planchenault T, Baleux F, Staropoli I, Le-Barillec K, Leduc D, Delaunay T, Lazarini F, Virelizier JL, Chignard M, Pidard D, Arenzana-Seisdedos F, Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4, J. Biol. Chem. 2002 May;277(18):15677-89.
  • 2002
    Mulard LA, Clément MJ, Segat-Dioury F, Delepierre M, Synthesis and NMR study of a linear pentasaccharide fragment of the Shigella flexneri 5a O-specific polysaccharide, Tetrahedron 2002; 58: 2593-604.
  • 2002
    Mulard L, Alonso JM, Fournier JM, Vaccins polysaccharidiques, Annales de l'Institut Pasteur, Editions scientifiques et médicales Elsevier SAS 2002 p. 37-54.
  • 2001
    Nyholm PG, Mulard LA, Miller CE, Lew T, Olin R, Glaudemans CP, Conformation of the O-specific polysaccharide of Shigella dysenteriae type 1: molecular modeling shows a helical structure with efficient exposure of the antigenic determinant alpha-L-Rhap-(1–>2)-alpha-D-Galp, Glycobiology 2001 Nov;11(11):945-55.
  • 2001
    Mousson F, Beswick V, Coïc YM, Huynh-Dinh T, Sanson A, Neumann JM, Investigating the conformational coupling between the transmembrane and cytoplasmic domains of a single-spanning membrane protein. A 1H-NMR study, FEBS Lett. 2001 Sep;505(3):431-5.
  • 2001
    Mousson F, Beswick V, Coïc YM, Baleux F, Huynh-Dinh T, Sanson A, Neumann JM, Concerted influence of key amino acids on the lipid binding properties of a single-spanning membrane protein: NMR and mutational analysis, Biochemistry 2001 Aug;40(33):9993-10000.
  • 2001
    Sekowska A, Mulard L, Krogh S, Tse JK, Danchin A, MtnK, methylthioribose kinase, is a starvation-induced protein in Bacillus subtilis, BMC Microbiol. 2001;1:15.
  • 2001
    Schneider B, Meyer P, Sarfati S, Mulard L, Guerreiro C, Boretto J, Janin J, Véron M, Deville-Bonne D, Canard B, Activation of anti-reverse transcriptase nucleotide analogs by nucleoside diphosphate kinase: improvement by alpha-boranophosphate substitution, Nucleosides Nucleotides Nucleic Acids 2001 Apr-Jul;20(4-7):297-306.
  • 2000
    Selmi B, Boretto J, Navarro JM, Sire J, Longhi S, Guerreiro C, Mulard L, Sarfati S, Canard B, The valine-to-threonine 75 substitution in human immunodeficiency virus type 1 reverse transcriptase and its relation with stavudine resistance, J. Biol. Chem. 2001 Apr;276(17):13965-74.
  • 2000
    Sadir R, Baleux F, Grosdidier A, Imberty A, Lortat-Jacob H, Characterization of the stromal cell-derived factor-1alpha-heparin complex, J. Biol. Chem. 2001 Mar;276(11):8288-96.
  • 2000
    Roux M, Beswick V, Coïc YM, Huynh-Dinh T, Sanson A, Neumann JM, PMP1 18-38, a yeast plasma membrane protein fragment, binds phosphatidylserine from bilayer mixtures with phosphatidylcholine: a (2)H-NMR study, Biophys. J. 2000 Nov;79(5):2624-31.
  • 2000
    Costachel C, Sansonetti PJ, Mulard LA, Linear synthesis of the methyl glycosides of tetra- and pentasaccharide fragments specific for the Shigella flexneri serotype 2a O-antigen, J. Carbohydr. Chem. 2000; 19: 1131-50.
  • 2000
    Lazarini F, Casanova P, Tham TN, De Clercq E, Arenzana-Seisdedos F, Baleux F, Dubois-Dalcq M, Differential signalling of the chemokine receptor CXCR4 by stromal cell-derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes, Eur. J. Neurosci. 2000 Jan;12(1):117-25.
  • 2000
    Mulard LA, Ughetto-Monfrin J, Linear synthesis of the methyl glycosides of tri-, tetra-, and pentasaccharide fragments of the Shigella flexneri serotype 5a O-antigen, J Carbohydr Chem 2000; 19: 503-26.
  • 2000
    Mulard LA, Ughetto-Monfrin J, First synthesis of a branched pentasaccharide representative of the repeating unit of the Shigella flexneri serotype 5a O-antigen, J Carbohydr Chem 2000; 19: 193-220.
  • 1999
    Villeneuve S, Boutonnier A, Mulard LA, Fournier JM, Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1, Microbiology (Reading, Engl.) 1999 Sep;145 ( Pt 9):2477-84.
  • 1999
    Amara A, Lorthioir O, Valenzuela A, Magerus A, Thelen M, Montes M, Virelizier JL, Delepierre M, Baleux F, Lortat-Jacob H, Arenzana-Seisdedos F, Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine, J. Biol. Chem. 1999 Aug;274(34):23916-25.
  • 1999
    Beswick V, Guerois R, Cordier-Ochsenbein F, Coïc YM, Tam HD, Tostain J, Noël JP, Sanson A, Neumann JM, Dodecylphosphocholine micelles as a membrane-like environment: new results from NMR relaxation and paramagnetic relaxation enhancement analysis, Eur. Biophys. J. 1999;28(1):48-58.
  • 1999
    Mulard LA, Ughetto-Monfrin J, Synthesis of the methyl glycosides of a tri- and tetrasaccharide fragment specific for the Shigella flexneri serotype 5a O-antigen. A reinvestigation, J Carbohydr Chem 1999; 18: 721-53.
  • 1998
    Mulard LA, Glaudemans CP, Synthesis of tri- and tetrasaccharide fragments of the Shigella dysenteriae type 1 O-antigen deoxygenated and fluorinated at position 3 of the methyl alpha-D-galactopyranoside terminus, Carbohydr. Res. 1998 Sep;311(3):121-33.
  • 1998
    Miller CE, Mulard LA, Padlan EA, Glaudemans CP, Binding of modified fragments of the Shigella dysenteriae type 1 O-specific polysaccharide to monoclonal IgM 3707 E9 and docking of the immunodeterminant to its modeled Fv, Carbohydr. Res. 1998 Jul;309(3):219-26.
  • 1998
    Beswick V, Roux M, Navarre C, Coïc YM, Huynh-Dinh T, Goffeau A, Sanson A, Neumann JM, 1H- and 2H-NMR studies of a fragment of PMP1, a regulatory subunit associated with the yeast plasma membrane H(+)-ATPase. Conformational properties and lipid-peptide interactions, Biochimie 1998 May-Jun;80(5-6):451-9.
  • 1998
    Guijarro JI, Djavadi-Ohaniance L, Baleux F, Delepierre M, Goldberg ME, Does a peptide bound to a monoclonal antibody always adopt a unique conformation?, Res. Immunol. 1998 Feb;149(2):127-37.
  • 1997
    Coxon B, Sari N, Mulard LA, Kovàc P, Pozsgay V, Glaudemans CPJ, Investigation by NMR spectroscopy and molecular modeling of the conformations of some modified disaccharide antigens for Shigella dysenteriae type 1, J Carbohydr Chem 1997; 16: 927-46.
  • 1995
    Guijarro JI, González-Pastor JE, Baleux F, San Millán JL, Castilla MA, Rico M, Moreno F, Delepierre M, Chemical structure and translation inhibition studies of the antibiotic microcin C7, J. Biol. Chem. 1995 Oct;270(40):23520-32.
  • 1995
    Mulard LA, Claudemans CP, Synthesis of specifically deoxygenated disaccharide derivatives of the Shigella dysenteriae type 1 O-antigen, Carbohydr. Res. 1995 Sep;274:209-22.
  • 1994
    Mulard LA, Kovác P, Glaudemans CP, Synthesis of specifically monofluorinated ligands related to the O-polysaccharide of Shigella dysenteriae type 1, Carbohydr. Res. 1994 Jun;259(1):21-34.
  • 1994
    Mulard LA, Kovác P, Glaudemans CP, Fluorination at position 6 of derivatives of methyl alpha-D-galactopyranoside, Carbohydr. Res. 1994 Jun;259(1):117-29.
  • 1994
    Mulard LA, Kovác P, Glaudemans CP, Synthesis of methyl O-alpha-L-rhamnopyranosyl-(1–>2)-alpha-D-galactopyranosides specifically deoxygenated at position 3, 4, or 6 of the galactose residue, Carbohydr. Res. 1994 Jan;251:213-32.
  • 1993
    Czernecki S, Mulard L, Valery JM, Commercon A, Synthesis of 2′-deoxy-2′-spirocyclopropyl cytidine as potential inhibitor of Ribonucleoside Diphosphate Reductase, Can J Chem 1993; 71: 413-6.
  • 1991
    Delepierre M, Larvor MP, Baleux F, Goldberg ME, 1H-NMR conformational analysis of a high-affinity antigenic 11-residue peptide from the tryptophan synthase beta 2 subunit, Eur. J. Biochem. 1991 Nov;201(3):681-93.
Looking for something?
Research Structures
Teams Platforms Departments Transversal Research Centers Program Projects National Reference Centers WHOCCs
Keywords
Navigate by keyword
Teams
List by Head Name List by Department Laboratories UTechS Junior Group (G5) Technological Poles Platforms Groups Collections National Reference Centers WHOCCs
Events
All Conference Departmental Retreat HDR Defense Meeting PhD Thesis Seminar Symposium Summer School Training Workshop Past events
Network
Instituts Projects Members
News
All news
Guides
Tutorials & Videos
Welcome
IP campus
Calls
List all calls
Job offers
List all job offers
Courses
Upcoming courses Past courses
Alumni
Activity & news
Credits
• Terms & Conditions • Legal Notice
Coordinated by Nathalie de Parseval
contact
Scientific General Secretary of Institut Pasteur.
Designed by Yhello
contact
Yhello is a digital creation agency based in Paris, created by former scientists passionate about the web.